Appointment of Dean Schauer to Producto’s Board of Directors
The Producto Group announced today that it appointed Mr. Dean Schauer as the newest member of its Board of Directors, effective immediately. “We are delighted to welcome Dean to our Board of Directors,” said Adam Cook, Non-Executive Chairman of Producto and Chief Investment Officer of Culper Capital Partners. “Dean’s overwhelming success as a leader in the MedTech industry is well documented and he will make an immediate impact on our Company and team. Our CEO, COO, Board Member Declan Smyth (President of Franchise at Viant Medical) and Dean all have deep roots in the medical device space, I’m personally super excited to watch this team excel.”
Mr. Schauer will continue in his current role as the Chief Executive Officer and President of Confluent Medical Technologies, a position he has held since 2013. Prior to Confluent, he held the position of Executive Vice President and General Manager for Accellent’s Cardiovascular Business. Dean has also advanced from roles as Executive Vice President of Operations and Engineering, Executive Vice President of Sales and Marketing, Senior Vice President of Engineering and Customer Operations, Vice President of Engineering and Quality, Director of Program Management, and Engineering Manager.
“I am thrilled to join The Producto Group’s board,” expressed Mr. Schauer. “The Company’s growth trajectory, value proposition to its customers and the thought of partnering with Adam, Declan and the rest of the team made my decision to do this pretty easy. I look forward to some exciting days ahead.”